RETROPERITONEAL FIBROSIS DURING TREATMENT WITH METHYLDOPA
- 16 August 1975
- journal article
- Published by Elsevier in The Lancet
- Vol. 306 (7929) , 302-304
- https://doi.org/10.1016/s0140-6736(75)92733-6
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- SCLEROSING PERITONITIS, AN UNUSUAL REACTION TO A β-ADRENERGIC-BLOCKING DRUG (PRACTOLOL)The Lancet, 1974
- Systemic Lupus Erythematosus Syndrome Induced by PractololBMJ, 1973
- Rapid processing of kidney biopsies for electron microscopyKidney International, 1973
- ACQUIRED HAEMOLYTIC ANAEMIAActa Medica Scandinavica, 1973
- The pathology of idiopathic retroperitoneal fibrosisJournal of Clinical Pathology, 1970
- POSITIVE DIRECT COOMBS TESTS AND ANTINUCLEAR FACTOR IN PATIENTS TREATED WITH METHYLDOPAThe Lancet, 1967
- CARDIAC AND PULMONARY FIBROSIS DURING METHYSERGIDE THERAPY FOR HEADACHEThe Lancet Healthy Longevity, 1967
- INCIDENCE OF A POSITIVE DIRECT COOMBS TEST IN PATIENTS ON α-METHYLDOPAThe Lancet, 1966
- The effect of hydralazine (apresoline) on collagen synthesis in carrageenin granulomasArthritis & Rheumatism, 1965
- Dermal Chemical Response to Analogues of Dilantin**From the Biochemical Research Laboratory, Children's Hospital Research Foundation, Washington 9, D. C. and Department of Biochemistry, Georgetown University Medical Center, Washington 7, D. C.Journal of Investigative Dermatology, 1963